Week 4 - Ethics Game Simulation Essay

Ethics Game Simulation

No Name

MGT/216

September XX, 20XX
No Name
Ethical Issues
      G-BioSport is a business that supplies its customers with sports supplements that adhere to the Food and Drug Administration (FDA).   G-BioSport had persuaded the FDA to employ elevated quality control standards.   However, the most recent batch of products set for sampling had arrived two weeks late, revealing 100% of the samples tested positive for trace contaminants.   This indicated that the entire batch was tainted with contaminants.   Although the contaminated products would not affect all individuals or consumers, this was indeed a huge concern.   The levels of contamination were well below the current FDA standards and allegedly would not cause adverse reactions in healthy adults.   However, a probability of adverse reactions exists in adults with mediocre immune systems.   Consequently, it was my responsibility as the quality control manager to make a decision to pull all of the contaminated products, inform or warn consumers (existing and potential), or extend a refund or replacement policy for contaminated products.
Decision-Making Steps
      The decision-making steps I made to ethically address the issue in the first dilemma was first to decide whether or not to recall the product altogether, disseminate the information about the contamination and possible risks involved with consumption, provide refunds, or replace the product.   Unfortunately, these decisions did not come to me as intuitively as I would have liked.   I later analyzed the issues to gain a comprehensible perception of each issue.   An analysis of the stakeholders was conducted to identify low to high risks for the shareholders and the CEO of G-BioSport.   My conclusion was based on the duties that I should advocate ethically within the company and of personal belief which was to disseminate the information broadly regarding risk for specific groups, and offer to refund or replace the contaminated...